Total Funding
27
26
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
156420
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.
Manuela Niewel: SVP Clinical- Anne Burger: CFO
About the Company
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.
